FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16223411000001101: Prezista 150mg tablets (Janssen-Cilag Ltd) 240 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Dec 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57263101000001111 Prezista 150mg tablets (Janssen-Cilag Ltd) 240 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57263201000001116 Prezista 150mg tablets (Janssen-Cilag Ltd) 240 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prezista 150mg tablets (Janssen-Cilag Ltd) 240 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Prezista 150mg tablets (Janssen-Cilag Ltd) 240 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Prezista 150mg tablets (Janssen-Cilag Ltd) 240 tablet Is a Darunavir 150mg tablets 240 tablet true Inferred relationship Existential restriction modifier
Prezista 150mg tablets (Janssen-Cilag Ltd) 240 tablet Has AMP Prezista 150mg tablets (Janssen-Cilag Ltd) true Inferred relationship Existential restriction modifier
Prezista 150mg tablets (Janssen-Cilag Ltd) 240 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Prezista 150mg tablets (Janssen-Cilag Ltd) 240 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Prezista 150mg tablets (Janssen-Cilag Ltd) 240 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Prezista 150mg tablets (Janssen-Cilag Ltd) 240 tablet Has specific active ingredient Darunavir ethanolate true Inferred relationship Existential restriction modifier
Prezista 150mg tablets (Janssen-Cilag Ltd) 240 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Prezista 150mg tablets (Janssen-Cilag Ltd) 240 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Darunavir true Inferred relationship Existential restriction modifier
Prezista 150mg tablets (Janssen-Cilag Ltd) 240 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Prezista 150mg tablets (Janssen-Cilag Ltd) 240 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Prezista 150mg tablets (Janssen-Cilag Ltd) 240 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Prezista 150mg tablets (Janssen-Cilag Ltd) 240 tablet Has basis of strength substance Darunavir true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start